The Venture Codex Logo

The Venture Codex

Cancer Research Institute

29 Broadway, Floor 4, New York, NY, 10006, United States

Overview

Nonprofit organization advancing cancer immunotherapy research and funding.

Founded

1953

Deals ยท 12mo

0

Links

WebsiteLinkedInX (Twitter)

Stage focus

Seed
Series A
Series B

Geographic focus

United Kingdom
United States

Sector focus

Biotechnology
Education
Medical
Non Profit

Investment portfolio

5rounds
NAMEDATESIZE
OverT Bio
May 2024Participated
$16 MSeed
Infinitopes
May 2024Participated
$16 MSeed
SURGE Therapeutics
Jul 2023Participated
$32 MSeries B
SURGE Therapeutics
Oct 2022Participated
$26 MSeries A
Cartography Biosciences
Jul 2022Participated
$57 MSeries A
OverT Bio
May 2024Participated
$16 MSeed
Infinitopes
May 2024Participated
$16 MSeed
SURGE Therapeutics
Jul 2023Participated
$32 MSeries B
SURGE Therapeutics
Oct 2022Participated
$26 MSeries A
Cartography Biosciences
Jul 2022Participated
$57 MSeries A
5
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Cancer Research Institute: 5 funding rounds are recorded in the selected participation categories.All available history.
Cancer Research Institute: 5 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed02
Series A02
Series B01

Monthly Deal Activity

Cancer Research Institute: 5 deals are recorded across 52 months.All available history.
Cancer Research Institute: 5 deals are recorded across 52 months. All available history
MonthDeals
Jul '221
Aug '220
Sep '220
Oct '221
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '231
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '242
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Cancer Research Institute: Health & Life Sciences is the largest displayed sector by deal count (5 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Cancer Research Institute: Health & Life Sciences is the largest displayed sector by deal count (5 deals). All available history
SectorDeals
Health & Life Sciences5

Deal Size Distribution

Cancer Research Institute: 5 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Cancer Research Institute: 5 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M2
$25M-$50M2
$50M-$100M1
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Cancer Research Institute: United States has the largest recorded deal count among the displayed regions (4 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Cancer Research Institute: United States has the largest recorded deal count among the displayed regions (4 deals). All available history
RegionDeals
United States4
Europe1
Cancer Research Institute: 20 co-investors are shown, with 8VC sharing 3 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Cancer Research Institute: 20 co-investors are shown, with 8VC sharing 3 recorded deals. All available history
Co-investorShared deals
8VC3
Alexandria Venture Investments2
Alumni Ventures2
ARTIS Ventures2
Camford Capital2
Gaingels2
Intuitive Ventures2
Khosla Ventures2
Pitango HealthTech2
Wing Venture Capital2
AME Cloud Ventures1
Andreessen Horowitz1
Bioluminescence Ventures1
Cancer Research Horizons1
Catalio Capital Management1
Civilization Ventures1
CRIS Cancer Foundation1
Fusion Fund1
Hawktail1
KdT Ventures1

Investment Strategy

Cancer Research Institute: Led accounts for 0% and participating for 100% of round participation.All available history.
Cancer Research Institute: Led accounts for 0% and participating for 100% of round participation. All available history
CategoryDeals (count)Share (%)
Led00%
Participating5100%
Cancer Research Institute: Single-lead accounts for 0% and co-led for 0% of lead dynamics.All available history.
Cancer Research Institute: Single-lead accounts for 0% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led00%

Lead dynamics requires at least one led deal in this range

Team

Jill O'Donnell Tormey

Chief Executive Officer & Director of Scientific Affairs

Peter Bloom

Trustee